Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
Ashley Noisette, Marc C Hochberg Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA Abstract: Psoriatic arthritis (PsA) is a heterogeneous disease with several clinical subtypes including peripheral arthritis, dacty...
Main Authors: | Noisette A, Hochberg MC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-07-01
|
Series: | Psoriasis : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/abatacept-for-the-treatment-of-adults-with-psoriatic-arthritis-patient-peer-reviewed-article-PTT |
Similar Items
-
Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
by: Vibeke Strand, et al.
Published: (2018-12-01) -
Efficacy and Metabolic Effect on Serum Lipids of Apremilast in Psoriatic Arthritis: A Case Report
by: Roberta Gualtierotti, et al.
Published: (2019-03-01) -
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
by: Yannick Degboé, et al.
Published: (2020-06-01) -
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
by: O. Yu. Olisova, et al.
Published: (2019-07-01) -
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
by: Ernest Choy, et al.
Published: (2021-02-01)